Identification of an HLA-A(*)0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein

The development of T-cell-based immunotherapies of cancer largely depends on the availability of tumour-associated antigens capable of eliciting tumour-directed cytotoxic T-cell responses. In prostate cancer, the number of antigens defined as suitable targets of cytotoxic T lymphocytes (CTLs) is sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiessling, A, Stevanovic, S, Füssel, S, Weigle, B, Rieger, M A, Temme, A, Rieber, E P, Schmitz, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410218/
https://www.ncbi.nlm.nih.gov/pubmed/14997204
http://dx.doi.org/10.1038/sj.bjc.6601642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410218/
https://www.ncbi.nlm.nih.gov/pubmed/14997204
http://dx.doi.org/10.1038/sj.bjc.6601642

Ejemplares similares